Who Paid My Doc
foresiGHt extension
ClinicalTrials.gov NCT05171855
Research payments
$1,290,783
Through program year 2025, $1,290,783 in research payments was reported against foresiGHt extension, across 197 payments, paid by Ascendis Pharma, Inc..
- Paid by
- Ascendis Pharma, Inc.
- ClinicalTrials.gov
- NCT05171855
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $281,882 | 61 |
| 2024 | Research | $530,509 | 96 |
| 2023 | Research | $478,392 | 40 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Kevin Yuen Phoenix, AZ Named on 50 payments
- Maria Fleseriu Portland, OR Named on 20 payments
- Christina Wang Torrance, CA Named on 18 payments
- Irina Bancos Rochester, MN Named on 15 payments
- Julie Silverstein Saint Louis, MO Named on 12 payments
- Oksana Hamidi Dallas, TX Named on 11 payments
- Georgiana Dobri Cleveland Heights, OH Named on 10 payments
- Nidhi Agrawal New York, NY Named on 10 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.